Cited by 13Malaria Research and ControlVaccine Coverage and HesitancyTravel-related health issues

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

A narrative review of the RTS S AS01 malaria vaccine and its implementation in Africa to reduce the global malaria burden

Open access

Abstract

The RTS, S/AS01 vaccine is a significant milestone in advancing malaria control, especially in Africa, where the heavy burden of this disease is prevalent. The objective of this study is to discuss the effectiveness and utilization of the RTS, S/AS01 vaccine in Africa while simultaneously addressing the gaps and associated issues. We also explore briefly the R21/Matrix-M vaccines recommended by the World Health Organization (WHO) for children aged five months and older. Essential considerations include but are not limited to the vaccine's effectiveness, implementation challenges, available funding sources, public acceptance, and compatibility with various conventional prevention methods for malaria, like insecticide-coated bed nets and antimalarial medicines. This paper also examines the global practices for integrating vaccines into public health systems and policies while emphasizing sustainable and equitable approaches. By drawing from the lessons learned from the implementations of pilot programs as well as early adoption of the RTS, S/AS01 malaria vaccine, this perspective study tries to identify the key factors that may enhance the impact of the vaccine in the fight against malaria and significantly contribute to the vision of complete eradication the disease. Further research needs to be carried out regarding the efficacy and duration of protection of the RTS, S/AS01 vaccine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12982-024-00284-w

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 5

  1. WHO guidelines for malaria [Internet]. Geneva: World Health Organization: https://www.ncbi.nlm.nih.gov/books/NBK588130/. Accessed 16 Feb 2021
  2. Ndeketa L, Mategula D, Terlouw DJ, Bar-Zeev N, Sauboin CJ, Biernaux S. Cost-effectiveness and public health impact of RTS, S/AS01 E malaria vaccine in Malawi, using a Markov static model. Welcome Open Res. 2021. https://doi.org/10.1268/wellcomeopenres.16224.2. · DOI
  3. Mutombo AM, Mukuku O, Tshibanda KN, et al. Severe malaria and death risk factors among children under 5 years at Jason Sendwe hospital in democratic republic of Congo. Pan Afr Med J. 2018. https://doi.org/10.1160/pamj.2018.29.184.15235. · DOI
  4. Hotez PJ. Vaccine preventable disease and vaccine hesitancy. Med Clin North Am. 2023;107(6):979–87. https://doi.org/10.1016/j.mcna.2023.05.01. · DOI
  5. World Health Organization. Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2023.

Cited by

Sorted by citations

See all 13

Metadata

Authors
Ogieuhi, I. J., Ajekiigbe, V. O., Kolo-Manma, K., Akingbola, A., Odeniyi, T. A., Soyemi, T. S., Ayomide, J. H., Thiyagarajan, B., & Awolola, B. D.
Affiliations
  • Siberian State Medical University (RU)
  • Ladoke Akintola University of Technology (NG)
  • University of Cambridge (GB)
  • Far Eastern Federal University (RU)
  • Bowen University (NG)
Corresponding author
Ogieuhi, Ikponmwosa Jude
Venue
Discover Public Health
Published
2024-10-25
Volume
21
Issue
1
ISSN
3005-0774 (ISSN-L)
OpenAlex
W4403770875
Cited by
13
References
45
Citations by year
2026: 7 · 2025: 6
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • Discover Public Health (publishedVersion, cc-by-nc-nd)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
Keywords
RTS,S/AS01 vaccine, malaria vaccine, vaccine implementation, vaccine effectiveness, vaccine uptake, vaccine financing, insecticide-treated nets, antimalarial drugs, pilot project, malaria eradication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review